What NEOGEN CORP's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 1 | 6 |
| Sells | 1 | 1 |
| Total trades | 25 | 45 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 35,211 | 486,929 |
| Disposed | 16,624 | 31,981 |
| Net activity | +18,587 | +454,948 |
Common stock only — 12 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Yarwood Jeremy | Chief Scientific Officer | Nov 04 | Open-market sale · S | −9,051 | $12.67 | −$115K | 0 |
| Yarwood Jeremy | Chief Scientific Officer | Nov 03 | Withheld — tax / exercise cost · F | −7,156 | $11.82 | −$84.6K | 9,051 |
| Yarwood Jeremy | Chief Scientific Officer | Nov 03 | Exercise / conversion · M | +16,207 | $11.82 | +$192K | 16,207 |
| Freels Joe B | Chief Commercial Officer | Nov 02 | Grant / award · A | +6,345 | $11.82 | +$75K | 6,345 |
| Green Ronald D | Director | Oct 29 | Exercise / conversion · M | +1,776 | $12.21 | +$21.7K | 29,044 |
| Capello Jeffrey D | Director | Oct 29 | Exercise / conversion · M | +1,776 | $12.21 | +$21.7K | 42,892 |
| Hastings Gregory S | VP, Animal Health | Oct 29 | Withheld — tax / exercise cost · F | −337 | $12.21 | −$4.11K | 33,449 |
| Hastings Gregory S | VP, Animal Health | Oct 29 | Exercise / conversion · M | +1,211 | $12.21 | +$14.8K | 33,786 |
| Gupta Aashima | Director | Oct 29 | Exercise / conversion · M | +1,776 | $12.21 | +$21.7K | 38,180 |
| Rodriguez Rafael A | Director | Oct 29 | Exercise / conversion · M | +1,776 | $12.21 | +$21.7K | 31,211 |
| Woteki Catherine E | Director | Oct 29 | Exercise / conversion · M | +1,776 | $12.21 | +$21.7K | 29,507 |
| Borel James C | Director | Oct 29 | Exercise / conversion · M | +1,776 | $12.21 | +$21.7K | 106,737 |
| Hastings Gregory S | VP, Animal Health | Oct 14 | Withheld — tax / exercise cost · F | −80 | $12.00 | −$960 | 32,575 |
| Hastings Gregory S | VP, Animal Health | Oct 14 | Exercise / conversion · M | +287 | $12.00 | +$3.44K | 32,655 |
| Nassif Mikheal | CEO | Oct 09 | Open-market buy · P | +505 | $11.95 | +$6.03K | 1,579 |
| Wainer Andrea F | Director | Oct 01 | Grant / award · A | +9,804 | $12.24 | +$120K | 11,834 |
| Woteki Catherine E | Director | Oct 01 | Grant / award · A | +9,804 | $12.24 | +$120K | 28,921 |
| Pelossof Avi | Director | Oct 01 | Grant / award · A | +9,804 | $12.24 | +$120K | 9,804 |
| Capello Jeffrey D | Director | Oct 01 | Grant / award · A | +9,804 | $12.24 | +$120K | 42,306 |
| Gupta Aashima | Director | Oct 01 | Grant / award · A | +9,804 | $12.24 | +$120K | 37,594 |
Loading...